{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:21:32Z","timestamp":1792423292835,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Austrian Science Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00259-019-04452-y","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T02:02:46Z","timestamp":1565661766000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":152,"title":["PET\/MRI versus PET\/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8786-8686","authenticated-orcid":false,"given":"Marius E.","family":"Mayerhoefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Prosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Tamandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hoeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Berzaczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Raderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Hochmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kiesewetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Scheuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ba-Ssalamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Karanikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kesselbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Dieckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Polterauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Rausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Brauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Eidherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Wadsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"4452_CR1","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.2967\/jnumed.116.174169","volume":"57","author":"WP Fendler","year":"2016","unstructured":"Fendler WP, Czernin J, Herrmann K, et al. Variations in PET\/MRI operations: results from an international survey among 39 active sites. J Nucl Med. 2016;57:2016\u201321.","journal-title":"J Nucl Med"},{"key":"4452_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12149-015-1050-y","volume":"30","author":"S Ishii","year":"2016","unstructured":"Ishii S, Shimao D, Hara T, et al. Comparison of integrated whole-body PET\/MR and PET\/CT: is PET\/MR alternative to PET\/CT in routine clinical oncology? Ann Nucl Med. 2016;30:225\u201333.","journal-title":"Ann Nucl Med"},{"key":"4452_CR3","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00259-017-3797-y","volume":"44","author":"M Eiber","year":"2017","unstructured":"Eiber M, Rauscher I, Souvatzoglou M, et al. Prospective head-to-head comparison of (11)C-choline-PET\/MR and (11)C-choline-PET\/CT for restaging of biochemical recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2017;44:2179\u201388.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4452_CR4","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.ejrad.2016.08.020","volume":"85","author":"V Ruhlmann","year":"2016","unstructured":"Ruhlmann V, Ruhlmann M, Bellendorf A, et al. Hybrid imaging for detection of carcinoma of unknown primary: a preliminary comparison trial of whole-body PET\/MRI versus PET\/CT. Eur J Radiol. 2016;85:1941\u20137.","journal-title":"Eur J Radiol"},{"key":"4452_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/RLU.0000000000001344","volume":"42","author":"A Afaq","year":"2017","unstructured":"Afaq A, Fraioli F, Sidhu H, et al. Comparison of PET\/MRI with PET\/CT in the evaluation of disease status in lymphoma. Clin Nucl Med. 2017;42:e1\u20137.","journal-title":"Clin Nucl Med"},{"key":"4452_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1148\/radiol.2016152798","volume":"282","author":"I Joo","year":"2017","unstructured":"Joo I, Lee JM, Lee DH, et al. Preoperative assessment of pancreatic cancer with FDG PET\/MR imaging versus FDG PET\/CT Plus contrast-enhanced multidetector CT: a prospective preliminary study. Radiology. 2017;282:149\u201359.","journal-title":"Radiology"},{"key":"4452_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00330-016-4397-0","volume":"27","author":"BM Schaarschmidt","year":"2017","unstructured":"Schaarschmidt BM, Grueneisen J, Metzenmacher M, et al. Thoracic staging with (18)F-FDG PET\/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to (18)F-FDG PET\/CT? Eur Radiol. 2017;27:681\u20138.","journal-title":"Eur Radiol"},{"key":"4452_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1148\/radiol.2016151155","volume":"281","author":"AN Melsaether","year":"2016","unstructured":"Melsaether AN, Raad RA, Pujara AC, et al. Comparison of whole-body (18)F FDG PET\/MR imaging and whole-body (18)F FDG PET\/CT in terms of lesion detection and radiation dose in patients with breast cancer. Radiology. 2016;281:193\u2013202.","journal-title":"Radiology"},{"key":"4452_CR9","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.2967\/jnumed.114.138974","volume":"55","author":"G Lee","year":"2014","unstructured":"Lee G, I H, Kim SJ, et al. Clinical implication of PET\/MR imaging in preoperative esophageal cancer staging: comparison with PET\/CT, endoscopic ultrasonography, and CT. J Nucl Med. 2014;55:1242\u20137.","journal-title":"J Nucl Med"},{"key":"4452_CR10","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1007\/s00330-016-4255-0","volume":"26","author":"SM Lee","year":"2016","unstructured":"Lee SM, Goo JM, Park CM, et al. Preoperative staging of non-small cell lung cancer: prospective comparison of PET\/MR and PET\/CT. Eur Radiol. 2016;26:3850\u20137.","journal-title":"Eur Radiol"},{"key":"4452_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/RLU.0000000000001753","volume":"42","author":"D Berzaczy","year":"2017","unstructured":"Berzaczy D, Giraudo C, Haug AR, et al. Whole-body 68Ga-DOTANOC PET\/MRI versus 68Ga-DOTANOC PET\/CT in patients with neuroendocrine tumors: a prospective study in 28 patients. Clin Nucl Med. 2017;42:669\u201374.","journal-title":"Clin Nucl Med"},{"key":"4452_CR12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1148\/radiol.14140090","volume":"273","author":"MW Huellner","year":"2014","unstructured":"Huellner MW, Appenzeller P, Kuhn FP, et al. Whole-body nonenhanced PET\/MR versus PET\/CT in the staging and restaging of cancers: preliminary observations. Radiology. 2014;273:859\u201369.","journal-title":"Radiology"},{"issue":"2","key":"4452_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00259-018-4109-x","volume":"46","author":"Julian Kirchner","year":"2018","unstructured":"Kirchner J, Sawicki LM, Nensa F, et al. Prospective comparison of (18)F-FDG PET\/MRI and (18)F-FDG PET\/CT for thoracic staging of non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2018. \nhttps:\/\/doi.org\/10.1007\/s00259-018-4109-x\n\n.","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"4452_CR14","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1097\/RLU.0000000000001461","volume":"42","author":"T Sekine","year":"2017","unstructured":"Sekine T, Barbosa FG, Sah BR, et al. PET\/MR outperforms PET\/CT in suspected occult tumors. Clin Nucl Med. 2017;42:e88\u201395.","journal-title":"Clin Nucl Med"},{"key":"4452_CR15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00261-016-0985-3","volume":"42","author":"OA Catalano","year":"2017","unstructured":"Catalano OA, Coutinho AM, Sahani DV, et al. Colorectal cancer staging: comparison of whole-body PET\/CT and PET\/MR. Abdom Radiol (NY). 2017;42:1141\u201351.","journal-title":"Abdom Radiol (NY)"},{"key":"4452_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/RLI.0000000000000218","volume":"51","author":"C Giraudo","year":"2016","unstructured":"Giraudo C, Raderer M, Karanikas G, et al. 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance in lymphoma: comparison with 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and with the addition of magnetic resonance diffusion-weighted imaging. Investig Radiol. 2016;51:163\u20139.","journal-title":"Investig Radiol"},{"key":"4452_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1148\/radiol.13131306","volume":"269","author":"OA Catalano","year":"2013","unstructured":"Catalano OA, Rosen BR, Sahani DV, et al. Clinical impact of PET\/MR imaging in patients with cancer undergoing same-day PET\/CT: initial experience in 134 patients\u2014a hypothesis-generating exploratory study. Radiology. 2013;269:857\u201369.","journal-title":"Radiology"},{"key":"4452_CR18","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/bjc.2015.112","volume":"112","author":"OA Catalano","year":"2015","unstructured":"Catalano OA, Nicolai E, Rosen BR, et al. Comparison of CE-FDG-PET\/CT with CE-FDG-PET\/MR in the evaluation of osseous metastases in breast cancer patients. Br J Cancer. 2015;112:1452\u201360.","journal-title":"Br J Cancer"},{"key":"4452_CR19","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1007\/s00261-018-1665-2","volume":"43","author":"M Schwartz","year":"2018","unstructured":"Schwartz M, Gavane SC, Bou-Ayache J, et al. Feasibility and diagnostic performance of hybrid PET\/MRI compared with PET\/CT for gynecological malignancies: a prospective pilot study. Abdom Radiol (NY). 2018;43:3462\u20137.","journal-title":"Abdom Radiol (NY)."},{"key":"4452_CR20","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s00261-015-0409-9","volume":"40","author":"TA Hope","year":"2015","unstructured":"Hope TA, Pampaloni MH, Nakakura E, et al. Simultaneous (68)Ga-DOTA-TOC PET\/MRI with gadoxetate disodium in patients with neuroendocrine tumor. Abdom Imaging. 2015;40:1432\u201340.","journal-title":"Abdom Imaging"},{"key":"4452_CR21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00259-013-2660-z","volume":"41","author":"A Afshar-Oromieh","year":"2014","unstructured":"Afshar-Oromieh A, Haberkorn U, Schlemmer HP, et al. Comparison of PET\/CT and PET\/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging. 2014;41:887\u201397.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4452_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00259-013-2654-x","volume":"41","author":"CS Reiner","year":"2014","unstructured":"Reiner CS, Stolzmann P, Husmann L, et al. Protocol requirements and diagnostic value of PET\/MR imaging for liver metastasis detection. Eur J Nucl Med Mol Imaging. 2014;41:649\u201358.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4452_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/9781118140345.ch32","volume-title":"Radiochemical Syntheses","author":"Harald Eidherr","year":"2012","unstructured":"Eidherr H, Girschle F, Mitterhauser M, et al. Synthesis of [68Ga]gallium DOTA-(Tyr3)-octreotide acetata (68Ga-DOTATOC). In: Scott PJH, Hockley BG, editors. Radiochemical Syntheses, Volume 1, Radiopharmaceuticals for positron emission tomography. Hoboken: John Wiley & Sons. \nhttps:\/\/doi.org\/10.1002\/9781118140345.ch32\n\n."},{"key":"4452_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000443170","volume":"103","author":"B Niederle","year":"2016","unstructured":"Niederle B, Pape UF, Costa F, et al. ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum. Neuroendocrinology. 2016;103:125\u201338.","journal-title":"Neuroendocrinology"},{"key":"4452_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000443171","volume":"103","author":"M Falconi","year":"2016","unstructured":"Falconi M, Eriksson B, Kaltsas G, et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016;103:153\u201371.","journal-title":"Neuroendocrinology"},{"key":"4452_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.2967\/jnumed.113.129247","volume":"55","author":"I Rauscher","year":"2014","unstructured":"Rauscher I, Eiber M, F\u00fcrst S, et al. PET\/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET\/CT. J Nucl Med. 2014;55:724\u20139.","journal-title":"J Nucl Med"},{"key":"4452_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/RLI.0b013e31826f2de9","volume":"48","author":"P Stolzmann","year":"2013","unstructured":"Stolzmann P, Veit-Haibach P, Chuck N, et al. Detection rate, location, and size of pulmonary nodules in trimodality PET\/CT-MR: comparison of low-dose CT and Dixon-based MR imaging. Investig Radiol. 2013;48:241\u20136.","journal-title":"Investig Radiol"},{"key":"4452_CR28","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1148\/radiol.13130620","volume":"268","author":"H Chandarana","year":"2013","unstructured":"Chandarana H, Heacock L, Rakheja R, et al. Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET\/MR and PET\/CT imaging. Radiology. 2013;268:874\u201381.","journal-title":"Radiology"},{"key":"4452_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.lungcan.2008.04.013","volume":"63","author":"J S\u00e1nchez de Cos","year":"2009","unstructured":"S\u00e1nchez de Cos J, Sojo Gonz\u00e1lez MA, Montero MV, et al. Non-small cell lung cancer and silent brain metastasis. Survival and prognostic factors. Lung Cancer. 2009;63:140\u20135.","journal-title":"Lung Cancer"},{"key":"4452_CR30","doi-asserted-by":"publisher","first-page":"e211S","DOI":"10.1378\/chest.12-2355","volume":"143","author":"GA Silvestri","year":"2013","unstructured":"Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e211S\u201350S.","journal-title":"Chest"},{"key":"4452_CR31","doi-asserted-by":"publisher","first-page":"iii27","DOI":"10.1093\/annonc\/mdu199","volume":"25","author":"M Reck","year":"2014","unstructured":"Reck M, Popat S, Reinmuth N, et al. ESMO Guidelines Working Group. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25:iii27\u201339.","journal-title":"Ann Oncol"},{"key":"4452_CR32","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/annonc\/mdv187","volume":"26","author":"WE Eberhardt","year":"2015","unstructured":"Eberhardt WE, De Ruysscher D, Weder W, et al. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol. 2015;26:1573\u201388.","journal-title":"Ann Oncol"},{"key":"4452_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00259-015-3206-3","volume":"43","author":"MT Freitag","year":"2016","unstructured":"Freitag MT, Radtke JP, Hadaschik BA, et al. Comparison of hybrid (68)Ga-PSMA PET\/MRI and (68)Ga-PSMA PET\/CT in the evaluation of lymph node and bone metastases of prostate cancer. Eur J Nucl Med Mol Imaging. 2016;43:70\u201383.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4452_CR34","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s00259-016-3594-z","volume":"44","author":"MT Freitag","year":"2017","unstructured":"Freitag MT, Radtke JP, Afshar-Oromieh A, et al. Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in (68)Ga-PSMA-11-PET of PET\/CT and PET\/MRI: comparison with mpMRI integrated in simultaneous PET\/MRI. Eur J Nucl Med Mol Imaging. 2017;44:776\u201387.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04452-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04452-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04452-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T19:19:02Z","timestamp":1597173542000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04452-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4452"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04452-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"28 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MEM has received speaker honoraria and research support from Siemens Healthineers and speaker honoraria from Bristol-Myers Squibb. HP has received research support from Boehringer Ingelheim and speaker honoraria from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, MSD, Novartis, and Roche. AB has received honoraria for consultation from Bayer Healthcare and speaker honoraria from Bayer Healthcare and Siemens Healthineers. MH received speaker honoraria from AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, MSD, Novartis, Pfizer, and Roche. MR and BK have received speaker honoraria from Ipsen Pharma, Celgene, and Novartis. MW has received speaker honoraria from Novartis. MP has received honoraria for lectures, consultation, or advisory board participation from Bristol-Myers Squibb, Novartis, Gerson Lehrman Group, CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, and Merck Sharp & Dome. BB is employed by Siemens Healthineers. WW is a part-time employee of CBmed Ltd., Graz, Austria, and has received research grants from Scintomics, ITG, Ipsen Pharma, and Eckert-Ziegler AG as well as speaker honoraria from GE Healthcare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}